These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 9514060)

  • 1. Allelic imbalance at chromosome 17p13.3 (YNZ22) in breast cancer is independent of p53 mutation or p53 overexpression and is associated with poor prognosis at medium-term follow-up.
    Thompson AM; Crichton DN; Elton RA; Clay MF; Chetty U; Steel CM
    Br J Cancer; 1998 Mar; 77(5):797-800. PubMed ID: 9514060
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Expression of the Hypermethylated in Cancer gene (HIC-1) is associated with good outcome in human breast cancer.
    Nicoll G; Crichton DN; McDowell HE; Kernohan N; Hupp TR; Thompson AM
    Br J Cancer; 2001 Dec; 85(12):1878-82. PubMed ID: 11747329
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Human breast cancer: frequent p53 allele loss and protein overexpression.
    Singh S; Simon M; Meybohm I; Jantke I; Jonat W; Maass H; Goedde HW
    Hum Genet; 1993 Feb; 90(6):635-40. PubMed ID: 8444469
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mutations of the p53 gene and loss of heterozygosity at chromosome 17p13.1 are associated with increased survivin expression in breast cancer.
    Tsuji N; Furuse K; Asanuma K; Furuya M; Kondoh K; Kamagata C; Sasaki M; Kobayashi D; Yagihashi A; Takahashi H; Watanabe N
    Breast Cancer Res Treat; 2004 Sep; 87(1):23-31. PubMed ID: 15377848
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Enhanced prediction of breast cancer prognosis by evaluating expression of p53 and prostate-specific antigen in combination.
    Yu H; Levesque MA; Clark GM; Diamandis EP
    Br J Cancer; 1999 Oct; 81(3):490-5. PubMed ID: 10507775
    [TBL] [Abstract][Full Text] [Related]  

  • 6. p53 allele losses, mutations and expression in breast cancer and their relationship to clinico-pathological parameters.
    Thompson AM; Anderson TJ; Condie A; Prosser J; Chetty U; Carter DC; Evans HJ; Steel CM
    Int J Cancer; 1992 Feb; 50(4):528-32. PubMed ID: 1537617
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Genetic alterations in the region of the p53 gene on human chromosome 17 in colorectal cancer].
    Kashkin KN; Fleĭshman EV; Chumakov PM; Perevoshchikov AG
    Genetika; 1998 Aug; 34(8):1049-55. PubMed ID: 9777351
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Allelic loss on distal chromosome 17p is associated with poor prognosis in a group of Brazilian breast cancer patients.
    Nagai MA; Pacheco MM; Brentani MM; Marques LA; Brentani RR; Ponder BA; Mulligan LM
    Br J Cancer; 1994 Apr; 69(4):754-8. PubMed ID: 7908218
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evidence for a gene on 17p13.3, distal to TP53, as a target for allele loss in breast tumors without p53 mutations.
    Cornelis RS; van Vliet M; Vos CB; Cleton-Jansen AM; van de Vijver MJ; Peterse JL; Khan PM; Børresen AL; Cornelisse CJ; Devilee P
    Cancer Res; 1994 Aug; 54(15):4200-6. PubMed ID: 8033152
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mutation of the TP53 gene and allelic imbalance at chromosome 17p13 in ductal carcinoma in situ.
    Munn KE; Walker RA; Menasce L; Varley JM
    Br J Cancer; 1996 Nov; 74(10):1578-85. PubMed ID: 8932338
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Allelic loss of the p53 gene in colorectal cancer.
    Smith DR; Khine K; Goh HS
    Ann Acad Med Singap; 1995 May; 24(3):399-402. PubMed ID: 7574422
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Involvement of p53 gene in the allelic deletion of chromosome 17p in human ovarian tumors.
    Tsao SW; Mok CH; Oike K; Muto M; Goodman HM; Sheets EE; Berkowitz RS; Knapp RC; Lau CC
    Anticancer Res; 1991; 11(6):1975-82. PubMed ID: 1776830
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The relationship between allelic imbalance on 17p, p53 mutation and p53 overexpression in head and neck cancer.
    Götte K; Riedel F; Neubauer J; Schäfer C; Coy JF; Hörmann K
    Int J Oncol; 2001 Aug; 19(2):331-6. PubMed ID: 11445847
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Allelic imbalance and fine mapping of the 17p13.3 subregion in sporadic breast carcinomas.
    Hoff C; Mollenhauer J; Waldau B; Hamann U; Poustka A
    Cancer Genet Cytogenet; 2001 Sep; 129(2):145-9. PubMed ID: 11566345
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Loss of heterozygosity at 17p13.3-ter, distal to TP53, correlates with negative hormonal phenotype in sporadic breast cancer.
    Roncuzzi L; Brognara I; Baiocchi D; Amadori D; Gasperi-Campani A
    Oncol Rep; 2005 Aug; 14(2):471-4. PubMed ID: 16012732
    [TBL] [Abstract][Full Text] [Related]  

  • 16. High incidence of loss of heterozygosity at chromosome 17p13 in breast tumours from BRCA2 mutation carriers.
    Eiriksdottir G; Barkardottir RB; Agnarsson BA; Johannesdottir G; Olafsdottir K; Egilsson V; Ingvarsson S
    Oncogene; 1998 Jan; 16(1):21-6. PubMed ID: 9467939
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Genetic changes in breast carcinomas in an Icelandic population.
    Eyfjörd JE; Thorlacius S
    Pharmacogenetics; 1992 Dec; 2(6):309-16. PubMed ID: 1306132
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Genetic basis for p53 overexpression in human breast cancer.
    Davidoff AM; Humphrey PA; Iglehart JD; Marks JR
    Proc Natl Acad Sci U S A; 1991 Jun; 88(11):5006-10. PubMed ID: 2052583
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Poor correlation with loss of heterozygosity on chromosome 17p and p53 mutations in ovarian cancers.
    Sakamoto T; Nomura N; Mori H; Wake N
    Gynecol Oncol; 1996 Nov; 63(2):173-9. PubMed ID: 8910623
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Allelic loss at 1p34, 13q12, 17p13.3, and 17q21.1 correlates with poor postoperative prognosis in breast cancer.
    Emi M; Yoshimoto M; Sato T; Matsumoto S; Utada Y; Ito I; Minobe K; Iwase T; Katagiri T; Bando K; Akiyama F; Harada Y; Fukino K; Sakamoto G; Matsushima M; Iida A; Tada T; Saito H; Miki Y; Kasumi F; Nakamura Y
    Genes Chromosomes Cancer; 1999 Oct; 26(2):134-41. PubMed ID: 10469451
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.